Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.
about
Modulation of Hypercholesterolemia-Induced Oxidative/Nitrative Stress in the HeartPPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertaintyPeroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusionMyocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus GerbilsCiglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock.Oxidative stress as a mechanism of added sugar-induced cardiovascular disease.Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Pharmacological preconditioning and postconditioning with nicorandil attenuates ischemia/reperfusion-induced myocardial necrosis and apoptosis in hypercholesterolemic ratsAtherosclerosis and the Hypercholesterolemic AGE-RAGE AxisEffect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion.PPARγ and Its Role in Cardiovascular Diseases.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus.Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.2,4-Thiazolidinedione Treatment Improves the Innate Immune Response in Dairy Goats with Induced Subclinical Mastitis.Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy.Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice.
P2860
Q26770809-B0D7EE28-DD01-401F-BF09-8634F4179172Q27024799-61A92E59-3EC5-49D2-9590-68B679AFB314Q28478187-D6E4F6B3-A1A4-4507-B6AB-959B4714FB0FQ28553085-97227EE3-1836-4380-8EBE-C728CE9DCAECQ33764548-B9B4C028-6DEA-479E-BA6F-81E1FB9115BDQ34452521-85CC3745-7C14-49D8-99D8-A5E61622CA15Q35610092-778E58E2-3601-4528-920A-818AB3BAC422Q36065338-6BA720FA-6704-4D61-B078-06315921D26AQ36335701-6CF8C00A-B4A8-4617-B6E9-F83D71DED828Q36909193-56EA62B2-5F05-48AA-8176-BCE6697F1DF5Q37364782-2B054BAE-2303-4C2C-9158-1705D3BFAA0AQ37627571-53981005-DDC9-467A-863A-D339839392AEQ37926558-6CEFA9B4-AB38-4045-A3DA-E538291616BAQ38395463-1CBFBAC6-5C01-4D6F-80B3-0963B593BAA2Q38640842-1E819BF0-E48A-4AFC-910A-7DD158186CC1Q38773916-81798A38-9A8C-4873-B1EB-A9A84D68D9BDQ39832237-7CF5EDA2-351A-4828-B2F9-133F781A15BCQ40121384-8057C815-D981-44BC-A494-4D96C8611768Q41773498-6ED0077D-7182-45D7-8115-9ED1AF8FF33FQ49413287-ADD3F717-21F3-4819-AEB5-152BC5CF6538
P2860
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@en
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@nl
type
label
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@en
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@nl
prefLabel
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@en
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@nl
P2093
P2860
P356
P1476
Rosiglitazone inhibits hyperch ...... tive effects of PPAR agonists.
@en
P2093
Bernard L Lopez
Hui-Rong Liu
Theodore A Christopher
Tian-Li Yue
Walter Koch
Xin-Liang Ma
P2860
P304
P356
10.1093/CVR/CVN308
P577
2008-11-14T00:00:00Z